Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Immunogenicity among Chimeric Antigen Receptor T Cell Therapy Recipients

Patients receiving chimeric antigen receptor T cell (CAR-T) therapy may have impaired humoral responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccinations owing to their underlying hematologic malignancy, prior lines of therapy, and CAR-T-associated hypogammaglobulinemia. C...

Descripción completa

Detalles Bibliográficos
Autores principales: Aleissa, Muneerah M., Little, Jessica S., Davey, Sonya, Saucier, Anna, Zhou, Guohai, Gonzalez-Bocco, Isabel H., Crombie, Jennifer L., Looka, Andrew, Baden, Lindsey R., Issa, Nicolas C., Hammond, Sarah P., Jacobson, Caron A., Sherman, Amy C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. 2023
Materias:
Brief Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995387/
https://www.ncbi.nlm.nih.gov/pubmed/36906276
http://dx.doi.org/10.1016/j.jtct.2023.03.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995387/
https://www.ncbi.nlm.nih.gov/pubmed/36906276
http://dx.doi.org/10.1016/j.jtct.2023.03.005

Ejemplares similares